CBU
REGN icon

CIBC Bancorp USA’s Regeneron Pharmaceuticals REGN Stock Holding History

CIBC Bancorp USA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Sell
21,340
-3,923
-16% -$2.67M 0.02% 489
2026
Q1 		$19.5M Buy
+25,263
New +$19.3M 0.03% 381
2025
Q3 		$10.1M Buy
+18,022
New +$10.2M 0.06% 252

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CIBC Bancorp USA's REGN Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Regeneron Pharmaceuticals (REGN) stake by 16% in Q2 2026, selling an estimated $2.67M and leaving 21,340 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #489.

CIBC Bancorp USA first reported a position in REGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $19.5M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • CIBC Bancorp USA held 21,340 shares of Regeneron Pharmaceuticals worth $13.3M as of Q2 2026.
  • CIBC Bancorp USA sold 3,923 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.67M.
  • Regeneron Pharmaceuticals made up 0.02% of CIBC Bancorp USA's portfolio in Q2 2026, its #489 holding.
  • CIBC Bancorp USA first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Regeneron Pharmaceuticals position peaked at $19.5M in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.